News in brief
Following its recent acquisition of the Kalabie ELN from Klee, Agilent Technologies has announced that the product will continue to be compatible with ChemAxon's cheminformatics products. The contract will follow the same terms as the original agreement between Klee and ChemAxon
The LHC@home service, which allows volunteers from around the world to share some of the enormous computational load from the Large Hadron Collider, is to be based in London, and managed by physicists from the GridPP project in the UK. The project was previously based at CERN in Geneva, Switzerland.
Ocimum Biosolutions is to buy Gene Logic’s genomics business for $10m in cash. The purchase includes Gene Logic’s extensive biological databases its Genesis gene expression software.